Verbifarma SRL
Verbifarma reported total assets of €1.47m at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Jul 2026).
The score of Verbifarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +56 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verbifarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Verbifarma's financial analysis
- Solvency31.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verbifarma
Verbifarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0661.885.339
- VAT number
- BE0661885339
- Peppol
- Registered · 0208:0661885339 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Sep 2016
- Registered office
- 8740 Pittem
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Verbifarma (SRL) has been based in Pittem since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 54,474 € and equity of 460,563 €; its revenue is not published. Its solvency stands at 31.4%, below the median of its sector (44.0%).
Companies similar to Verbifarma
Companies in the same business, of comparable size and area, outside its group.
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apolex Retail sale of pharmaceutical products Wichelen · balance sheet €1.47m
- Escapharm Retail sale of pharmaceutical products Kluisbergen · balance sheet €1.46m
- Apotheek DE Wilde ZEE Retail sale of pharmaceutical products Antwerp · balance sheet €1.48m
- Vanschoonbeek Farma Retail sale of pharmaceutical products Bekkevoort · balance sheet €1.50m
- VDV Pharma Retail sale of pharmaceutical products Schaerbeek · balance sheet €1.52m
Frequently asked questions about Verbifarma
What is the revenue of Verbifarma?
Verbifarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Verbifarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0661885339 for Verbifarma, if the company is VAT-registered. Its company number (CBE) is 0661.885.339.
Where is the registered office of Verbifarma?
According to the CBE register, the registered office of Verbifarma is in 8740 Pittem.
What is the equity of Verbifarma?
At the close of the 2025 financial year, the equity of Verbifarma amounts to 460,563 €, a solvency of 31.4% of total assets.
Who manages Verbifarma?
The register lists 1 active mandates at Verbifarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verbifarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →